Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) Growth (5y) (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) EPS (Basic) Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 39.74% |
| Jun 30, 2025 | 14.91% |
| Mar 31, 2025 | 66.22% |
| Dec 31, 2024 | 15.02% |
| Sep 30, 2024 | 41.20% |
| Jun 30, 2024 | 23.41% |
| Mar 31, 2024 | 14.88% |
| Dec 31, 2023 | 23.18% |
| Sep 30, 2023 | 22.70% |
| Jun 30, 2023 | 16.14% |
| Mar 31, 2023 | 7.14% |
| Dec 31, 2022 | 17.17% |
| Sep 30, 2022 | 26.95% |
| Jun 30, 2022 | 22.30% |
| Mar 31, 2022 | 14.49% |
| Sep 30, 2021 | -28.07% |
| Jun 30, 2021 | -33.81% |
| Mar 31, 2021 | -42.05% |
| Dec 31, 2020 | -27.50% |
| Sep 30, 2020 | -66.62% |